Cherry Creek Investment Advisors, Inc. Guardant Health, Inc. Transaction History

Cherry Creek Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	BUY	$43.66 - $61.0 $187,083 - $261,385	4,285 New	4,285 $231,000
Q1 2022 Apr 22, 2022	SELL	$48.25 - $100.49 $127,380 - $265,293	-2,640 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$88.71 - $120.43 $3,104 - $4,215	35 Added 1.34%	2,640 $264,000
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $285,950 - $431,596	2,605 New	2,605 $323,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.